Innovating Works
HORIZON-INFRA-2021-SERV-01-01
Research infrastructures services to support research addressing...
ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:
Sólo fondo perdido 0 €
European
This call is closed Esta línea ya está cerrada por lo que no puedes aplicar.
An upcoming call for this aid is expected, the exact start date of call is not yet clear.
Presentation: Consortium Consortium: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Minimum number of participants.
This aid finances Proyectos:

ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:

provision of innovative, customised and efficient RI services enhancing and increasing society’s long-term and consistent problem-solving capacity and evidence-based policy making in the health areas, including a better understanding of socio-economic implications;advancement of knowledge for personalised cancer prevention strategies and treatments;accelerated availability of solutions and products to patients in need;wider access to specialised R&I services to underpin the competitiveness of the European industry and of biotech SMEs developing new personalised cancer prevention strategies and treatments.
Scope:Proposals under this topic aim at integrating at EU level and providing access to a wide and inclusive portfolio of complementary research infrastructure services, including data services, and customised workflows supporting R&I projects along the development pipeline from discovery research to personalised treatment of cancer. Services should also support activities addressing the socio-economic dimension of cancer, the development of evide... see more

ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:

provision of innovative, customised and efficient RI services enhancing and increasing society’s long-term and consistent problem-solving capacity and evidence-based policy making in the health areas, including a better understanding of socio-economic implications;advancement of knowledge for personalised cancer prevention strategies and treatments;accelerated availability of solutions and products to patients in need;wider access to specialised R&I services to underpin the competitiveness of the European industry and of biotech SMEs developing new personalised cancer prevention strategies and treatments.
Scope:Proposals under this topic aim at integrating at EU level and providing access to a wide and inclusive portfolio of complementary research infrastructure services, including data services, and customised workflows supporting R&I projects along the development pipeline from discovery research to personalised treatment of cancer. Services should also support activities addressing the socio-economic dimension of cancer, the development of evidence-based public health measures and patient-centred approaches, as well as regulatory aspects of novel biomedical products or relevant biomarkers.

Proposals will support the provision of trans-national and/or virtual access to researchers as well as training for using the infrastructures, and activities to improve, customise and combine the services the infrastructures provide, so as to facilitate and integrate the access procedures and to further develop the remote or virtual provision of services.

In order to facilitate user access, different interfaces could be developed, offering tailored resources and services for different types of cancer or different classes of users.

Proposals should adhere to the guidelines and principles of the European Charter for Access to Research Infrastructures[1].

Proposals could foster cross-fertilisation by offering technologies involved in cancer advanced therapies to research projects targeting other major chronic disease.

Data management (and related ethics issues), interoperability, as well as the connection of digital services (e.g. data services) to the European Open Science Cloud, should be duly addressed.

Appropriate links and complementarities will be ensured with the Horizon Europe Mission on cancer[2]. Other major European or international initiatives, including the EU Beating Cancer Plan and the new EU biomedical research agency recently announced by the European Commission, should be duly taken into account. Whenever appropriate, proposals should foster the use and deployment of (open) global standards.

Proposals should make available to researchers the widest and most comprehensive portfolio of research infrastructures services which are relevant for the scope. To this extent, they should involve, as beneficiaries or as third parties, the necessary interdisciplinary set of research infrastructures of European interest[3] that provide such services. The inclusiveness of the proposal will be taken into account in the Excellence score. Proposals including only few of the research infrastructures services relevant to the scope will be scored lower.

Proposals should also look to establish active collaboration with clinical centres to facilitate translation of research results into clinical practice.

Research infrastructures from third countries[4] may be involved when appropriate, in particular when they offer complementary or more advanced services than those available in Europe.

Proposals should consider the inclusion of infrastructures that can facilitate a rapid transition of research findings to innovations and therefore, to society.

Proposals should include an outreach and engagement plan to actively advertise its services to targeted research communities and, if applicable, to relevant industries, including SMEs.

To identify and better exploit related synergies, share results and avoid overlaps, grants awarded under this topic should cooperate with those awarded under topic HORIZON-INFRA-2021-EOSC-01-06. To this extent, proposals should provide for dedicated activities and earmark appropriate resources.

Proposals are expected to exploit synergies and to ensure complementarity and coherence with other EU grants supporting access provision.

Proposals will include the list of services/installations[5] opened by research infrastructures for trans-national or virtual access and the amounts of units of access made available for users. Further conditions and requirements relating to access provisions that applicants should fulfil when drafting a proposal are given in the “Specific features for Research Infrastructures” section of this Work Programme. Compliance with these provisions will be taken into account during evaluation.


Cross-cutting Priorities:International CooperationEOSC and FAIR data


[1]https://ec.europa.eu/research/infrastructures/pdf/2016_charterforaccessto-ris.pdf

[2]https://ec.europa.eu/info/horizon-europe/missions-horizon-europe/cancer_en

[3]A research infrastructure is of European interest when is able to attract users from EU or associated countries other than the country where the infrastructure is located. This includes ESFRI and ERIC infrastructures.

[4]See the Eligibility conditions for this topic.

[5]“Installation” means a part or a service of a research infrastructure that can be used independently from the rest. A research infrastructure consists of one or more installations.

see less

Temáticas Obligatorias del proyecto: Temática principal: International Cooperation EOSC and FAIR data Anticancer therapy Personalised medicine Cancer and its biological basis

Consortium characteristics

Scope European : The aid is European, you can apply to this line any company that is part of the European Community.
Tipo y tamaño de organizaciones: The necessary consortium design for the processing of this aid needs:

characteristics of the Proyecto

Requisitos de diseño por participante: Duración:
Requisitos técnicos: ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes: ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:
Financial Chapters: The chapters of financing expenses for this line are:
Personnel costs.
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Subcontracting costs.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
Purchase costs.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Other cost categories.
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Indirect costs.
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Madurez tecnológica: The processing of this aid requires a minimum technological level in the project of TRL 4:. Los componentes que integran determinado proyecto de innovación han sido identificados y se busca establecer si dichos componentes individuales cuentan con las capacidades para actuar de manera integrada, funcionando conjuntamente en un sistema. + info.
TRL esperado:

Characteristics of financing

Intensidad de la ayuda: Sólo fondo perdido + info
Lost Fund:
For the eligible budget, the intensity of the aid in the form of a lost fund may reach as minimum a 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Guarantees:
does not require guarantees
No existen condiciones financieras para el beneficiario.

Additional information about the call

incentive effect: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
non -competitive competitive Very competitive
We do not know the total budget of the line
minimis: Esta línea de financiación NO considera una “ayuda de minimis”. You can consult the regulations here.

other advantages

SME seal: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
HORIZON-INFRA-2021-SERV-01 Research infrastructures services to support research addressing cancer ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes: provision of innovative, customised and...
Sin info.
HORIZON-INFRA-2021-SERV-01-06 Research infrastructures services for a sustainable and resilient agriculture and agro-ecological transitions
en consorcio: ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes: provision of innovative, customised and...
Cerrada does 9 months | next call scheduled for the month of
HORIZON-INFRA-2021-SERV-01-06 Implementing digital services to empower neuroscience research for health and brain inspired technology via EBRAINS
en consorcio:
Cerrada does 9 months | next call scheduled for the month of
HORIZON-INFRA-2021-SERV-01-06 Implementing digital services to empower neuroscience research for health and brain inspired technology via EBRAINS
en consorcio:
Cerrada does 9 months | next call scheduled for the month of
HORIZON-INFRA-2021-SERV-01-06 Implementing digital services to empower neuroscience research for health and brain inspired technology via EBRAINS
en consorcio:
Cerrada does 9 months | next call scheduled for the month of
HORIZON-INFRA-2021-SERV-01-06 Implementing digital services to empower neuroscience research for health and brain inspired technology via EBRAINS
en consorcio:
Cerrada does 9 months | next call scheduled for the month of